Brookfield
BNNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $42.39 Prior regular-session close from the quote source.
- $41.95–$42.63 Regular-session low and high so far today.
- 3.4M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $35.61–$49.57 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own BN if management consistently converts that scale into recurring operating cash flow and disciplined capital allocation, equity value should compound despite headline earnings volatility.
BN price history
Loading recent earnings…
Investment thesis
What must happen next
Brookfield's scale and asset operations will continue to increase operating cash flow, which is the true engine of shareholder value rather than volatile IFRS net income.StrengtheningMateriality: High
operating_cash_flow: $6,467,000,000 (2023) -> $7,569,000,000 (2024) -> $10,958,000,000 (2025). If OCF keeps growing, management can fund acquisitions, pay distributions and compound equity value; if OCF falls, the apparent asset scale won't translate into shareholder returns.
Watch: A sustained drop in yields from core assets (e.g., lower toll/utility/lease income or higher vacancy) that reduces recurring cash flows.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
operating_cash_flow: $6,467,000,000 (2023) -> $7,569,000,000 (2024) -> $10,958,000,000 (2025).
Open source ↗Brookfield's growing asset base and sizeable equity provide capacity to deploy capital into higher-return investments and to scale fee-bearing businesses, enabling future growth if allocation is disciplined.HoldingMateriality: High
assets: $441,284,000,000 (2023) -> $490,424,000,000 (2024) -> $518,971,000,000 (2025). Capacity to deploy at attractive returns is how the company leverages scale into long-term value; misuse of that capacity (overpaying, poor leverage) would destroy value.
Watch: Rising liabilities and leverage (liabilities: $321.85B -> $325.04B -> $352.78B) could raise funding risk if asset returns decline.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
assets: $441,284,000,000 (2023) -> $490,424,000,000 (2024) -> $518,971,000,000 (2025).
Open source ↗Reported net income and EPS will remain volatile because they include valuation and realization effects; therefore the correct valuation hinge is persistent operating cash flow and fee income rather than headline net income swings.HoldingMateriality: Medium
net_income: $5,105,000,000 (2023) -> $1,853,000,000 (2024) -> $3,235,000,000 (2025). If investors focus on net income volatility, the stock will be cyclically punished; if Brookfield grows recurring cash/fee income, valuation should become less volatile and re-rate higher.
Watch: If recurring fee revenue or operating margins do not rise and instead realized/ unrealized losses occur, net income volatility could persist and depress the multiple.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
net_income: $5,105,000,000 (2023) -> $1,853,000,000 (2024) -> $3,235,000,000 (2025).
Open source ↗Brookfield's cash balance and equity cushion reduce short-term financing risk and allow opportunistic, contrarian deployments during dislocations.StrengtheningMateriality: Medium
cash: $11,222,000,000 (2023) -> $15,051,000,000 (2024) -> $16,242,000,000 (2025). A healthy liquidity position enables accretive buying in downturns and avoids fire sales; loss of that buffer would force value-destructive actions.
Watch: Large, sustained share buybacks or special distributions that materially reduce cash could limit flexibility.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
cash: $11,222,000,000 (2023) -> $15,051,000,000 (2024) -> $16,242,000,000 (2025).
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Brookfield's scale and asset operations will continue to increase operating cash flow, which is the true engine of shareholder value rather than volatile IFRS net income. If OCF keeps growing, management can fund acquisitions, pay distributions and compound equity value; if OCF falls, the apparent asset scale won't translate into shareholder returns.
Brookfield's growing asset base and sizeable equity provide capacity to deploy capital into higher-return investments and to scale fee-bearing businesses, enabling future growth if allocation is disciplined. Capacity to deploy at attractive returns is how the company leverages scale into long-term value; misuse of that capacity (overpaying, poor leverage) would destroy value.
Reported net income and EPS will remain volatile because they include valuation and realization effects; therefore the correct valuation hinge is persistent operating cash flow and fee income rather than headline net income swings. If investors focus on net income volatility, the stock will be cyclically punished; if Brookfield grows recurring cash/fee income, valuation should become less volatile and re-rate higher.
Brookfield's cash balance and equity cushion reduce short-term financing risk and allow opportunistic, contrarian deployments during dislocations. A healthy liquidity position enables accretive buying in downturns and avoids fire sales; loss of that buffer would force value-destructive actions.
All standing thesis claims
Original report summary
management consistently converts that scale into recurring operating cash flow and disciplined capital allocation, equity value should compound despite headline earnings volatility.
Bull case and bear case
Bull case and bear case for BROOKFIELD
Where the evidence on BROOKFIELD stands: Holding on the latest evidence (Nov 10, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
Brookfield's scale and asset operations will continue to increase operating cash flow, which is the true engine of shareholder value rather than volatile IFRS net income.
Brookfield's growing asset base and sizeable equity provide capacity to deploy capital into higher-return investments and to scale fee-bearing businesses, enabling future growth if allocation is disciplined.
Reported net income and EPS will remain volatile because they include valuation and realization effects; therefore the correct valuation hinge is persistent operating cash flow and fee income rather than headline net income swings.
Brookfield's cash balance and equity cushion reduce short-term financing risk and allow opportunistic, contrarian deployments during dislocations.
Bear case: what would count against it
A sustained drop in yields from core assets (e.g., lower toll/utility/lease income or higher vacancy) that reduces recurring cash flows.
Rising liabilities and leverage (liabilities: $321.85B -> $325.04B -> $352.78B) could raise funding risk if asset returns decline.
If recurring fee revenue or operating margins do not rise and instead realized/ unrealized losses occur, net income volatility could persist and depress the multiple.
Thesis-Break Engine
What has broken in BROOKFIELD’s thesis
Each break OptimistFi flagged on BROOKFIELD, dated — with what has historically followed the same kind of break across the market, not a forecast for BROOKFIELD.
- Sharp drawdowncondition set before this filing
Across all companies, this kind of break has happened 15,428 times before. Those stocks beat comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedForeign issuer material report (6-K).
BROOKFIELD filed an SEC report on 2026-10-22: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
BROOKFIELD filed an SEC report on 2026-10-16: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
BROOKFIELD filed an SEC report on 2026-10-09: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A sustained drop in yields from core assets (e.g., lower toll/utility/lease income or higher vacancy) that reduces recurring cash flows.
- Rising liabilities and leverage (liabilities: $321.85B -> $325.04B -> $352.78B) could raise funding risk if asset returns decline.
- If recurring fee revenue or operating margins do not rise and instead realized/ unrealized losses occur, net income volatility could persist and depress the multiple.
- Large, sustained share buybacks or special distributions that materially reduce cash could limit flexibility.
BN news
Loading headlines…
Financial statements
BN income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
BN: quick answers
- What is BN's short interest?
- As of October 30, 2026, 21.7M BN shares were sold short, down 1.6% from the count before. At the stock's average daily volume that is 4.0 days to cover. FINRA publishes the count twice a month. BN short interest history
- Which well-known investors own BN?
- 4 of the 37 well-known funds tracked here reported BN shares in their latest 13F filings. By share of the fund's portfolio: Pershing Square (Bill Ackman), 12.6%; Akre Capital Management (Chuck Akre), 10.1%; Markel Group (Tom Gayner), 3.7%. Fund portfolios
BN in well-known investors’ portfolios
4 of 37 funds reported BN shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Bill AckmanPershing Square | 12.6% | $2.4B | — | Q2 2026 |
| Chuck AkreAkre Capital Management | 10.1% | $516M | −28.8% | Q2 2026 |
| Tom GaynerMarkel Group | 3.7% | $477M | No change | Q3 2026 |
| Stephen MandelLone Pine Capital | 0.21% | $33.8M | −92.9% | Q2 2026 |
